Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.4.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.198NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.198NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
DJ.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.5NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBC.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CM.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BW.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.10.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FW.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.19 (Delta)NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AY.19 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-17480.9Singapore
N.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.15 (Delta)NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AY.15 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.113NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.113NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.10NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GA.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.423NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.423NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.550NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.550NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.261NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.261NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.5NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.320NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.320NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.33NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
C.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.635NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.635NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.21NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
C.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.14NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used